Bracco
Bracco Diagnostics provides the U.S. with a wide range of leading products to help you provide quality diagnostic imaging for your patients. From the nonionic iodinated contrast agent with the highest concentration available and support from landmark safety studies, to the extracellular gadolinium-based contrast agent with the highest relaxivity and an FDA-approved indication for MR angiography, to the line of barium sulfate products for use in gastrointestinal radiology and CT, and for which we are the only supplier, to innovative contrast media injectors for your CT and angiographic suites, and for both radiology and cardiology applications.
- Isovue® (Iopamidol)
- Isovue® – 250
- Isovue® – 300
- Isovue® – 370
- Isovue® – M200
- Isovue® – M300
- MultiHance® (Gadobenate Dimeglumine)
- ProHance® (Gadoteridol)
- Gastrografin®
- Reno – 30
- Reno – 60
- Reno – DIP
- Renografin® – 60
- Sinografin®
- Cystografin® Dilute
- Cystografin
Isovue (Iopamidol)
Isovue Prefilled Syringes for use with the Medrad injection systems provide efficient contrast media use and administration convenience. Isovue-370 is the highest concentration of contrast approved for CT in the U.S. and is an excellent agent to match the speed and power of MDCT. Isovue-M is indicated for myleography and is another example of the Bracco commitment to support specialized imaging applications.
Isovue - 250
Each mL of Isovue-250 (lopamidol Injection 51%) provides 510 mg iopamidol with 1 mg tromethamine and 0. 33 mg edetate calcium disodium. The solution contains approximately 0.036 mg (0.002 mEq) sodium and 250 mg organically bound iodine per mL.
| Cat No. | Description |
| 1317-05 | 10 x 50mL Vials / Box |
| 1317-02 | 10 x 100mL Bottles / Box |
| 1317-09 | 10 x 150mL Bottles / Box |
| 1317-41 | 10 x 200mL Bottles (Multi-Pack) / Box |
Isovue - 300
Each mL of Isovue-300 (lopamidol Injection 61%) provides 612 mg iopamidol with 1 mg tromethamine and 0.39 mg edetate calcium disodium. The solution contains approximately 0.043 mg (0.002 mEq) sodium and 300 mg organically bound iodine per mL.
| Cat No. | Description |
| 1315-25 | 10 x 30mL Vials / Box |
| 1315-30 | 10 x 50mL Vials / Box |
| 1315-47 | 10 x 75mL Bottles / Box |
| 1315-35 | 10 x 100mL Bottles / Box |
| 1315-50 | 10 x 150mL Bottles / Box |
| 1315-41 | 10 x 200mL Bottles (Multi-Pack) / Box |
| 1315-98 | 6 x 500mL Bottles (Multi-Pack) / Box |
Isovue - 370
Each mL of Isovue-370 (lopamidol Injection 76%) provides 755 mg iopamidol with 1 mg tromethamine and 0.48 mg edetate calcium disodium. The solution contains approximately 0.053 mg (0.002 mEq) sodium and 370 mg organically bound iodine per mL.
| Cat No. | Description |
| 1316-30 | 10 x 50mL Vials / Box |
| 1316-52 | 10 x 75mL Bottles / Box |
| 1316-35 | 10 x 100mL Bottles / Box |
| 1316-04 | 10 x 125mL Bottles / Box |
| 1316-37 | 10 x 150mL Bottles / Box |
| 1316-41 | 10 x 200mL Bottles / Box |
| 1316-56 | 10 x 75mL Pre-Filled Syringes with Pressure Tubing / Box |
| 1316-57 | 10 x 100mL Pre-Filled Syringes with Pressure Tubing / Box |
| 1316-59 | 10 x 125mL Pre-Filled Syringes with Pressure Tubing / Box |
| 1316-41 | 10 x 200mL Bottles (Multi-Pack) / Box |
| 1316-98 | 6 x 500mL Bottles (Multi-Pack) / Box |
Isovue - M200
| Cat No. | Description |
| 1411-11 | 10 x 10mL Vials / Box |
| 1411-25 | 10 x 25mL Vials / Box |
Isovue - M300
| Cat No. | Description |
| 1412-15 | 10 x 15mL Vials / Box |
MultiHance (Gadobenate Dimeglumine)
MultiHance is an MRI contrast agent that has nearly twice the relaxtivity of other gadolinium-based contrast agents providing a marked increase in Signal-to-Noise Ratio (SNR) in T1-weighted images. MultiHance demonstrates weak and transient interactions with serum proteins that causes slowing in the molecular tumbling dynamics, resulting in strong increases in relaxivity in solutions containing serum proteins. The improved relaxation effect could potentially contribute to improved visualization.
| Cat No. | Description |
| 5164-12 | 5 x 5mL Vials / Pack |
| 5164-13 | 5 x 10mL Vials / Pack |
| 5164-14 | 5 x 15mL Vials / Pack |
| 5164-15 | 5 x 20mL Vials / Pack |
| 5264-16 | 5 x 50mL Bottles (Multi-Pack) |
| 5264-17 | 5 x 100mL Bottles (Multi-Pack) |
ProHance (Gadoteridol)
ProHance (Gadoteridol) injection, 279.3 mg/mL is the first macrocyclic, non-ionic MRI contrast agent approved for use in the U.S. for CNS MRI. ProHance has the lowest osmolality of all contrast agents in its class.
| Cat No. | Description |
| 1111-04 | 5 x 5mL Vials / Pack |
| 1111-01 | 5 x 10mL Vials / Pack |
| 1111-02 | 5 x 15mL Vials / Pack |
| 1111-03 | 5 x 20mL Vials / Pack |
| 1111-70 | 5 x 50mL Bottles (Multi-Pack) |
Gastrografin
A palatable lemon-flavored, water-soluble iodinated radiopaque contrast medium for oral or rectal administration used for radiographic examination of segments of the gastrointestinal tract and as an adjunct to contrast enhancement in CT of the torso.
| Cat No. | Description |
| 0445-35 | 24 x 30mL Bottles / Box |
| 0445-40 | 12 x 120mL Bottles / Box |
Reno - 30
Indicated for retrograde or ascending pyelography. This procedure may be used if intravenous excretion urography is contraindicated and it is also useful in complementing other diagnostic information.
| Cat No. | Description |
| 0804-45 | 25 x 50mL Vials / Box |
| 0804-44 | 10 x 50mL Vials / Box |
Reno - 60
Indicated in excretion urography (by direct I.V. or drip infusion); cerebral angiography; peripheral arteriography; venography; operative, T-tube, or percutaneous transhepatic cholangiography; splenoportography; arthrography and enhanced computed tomography (CT) of the brain and the body.
| Cat No. | Description |
| 0696-49 | 10 x 50mL Vials / Box |
Reno - DIP
Indicated for use in drip infusion pyelography in those patients in whom routine pyelography would not be expected to be, or has not been, satisfactory for diagnosis. It is not intended to replace retrograde pyelography where this procedure is indicated. Reno-DIP is also indicated for radiographic contrast enhancement in computed tomography (CT) of the brain and body.
| Cat No. | Description |
| 0809-75 | 10 x 300mL Bottles / Box |
Renografin - 60
Indicated in excretion urography (by direct I.V. or drip infusion); cerebral angiography; peripheral arteriography; venography; operative, T-tube, or percutaneous transhepatic cholangiography; splenoportography; arthrography; and discography and enhanced computed tomography (CT) of the brain and the body.
| Cat No. | Description |
| 0707-49 | 10 x 50mL Vials / Box |
| 0707-55 | 10 x 100mL Bottles / Box |
Sinografin
Indicated for use in hysterosalpingography.
| Cat No. | Description |
| 0523-30 | 10 x 10mL Vials / Box |
Cystografin Dilute
Indicated for retrograde cystourethrography.
| Cat No. | Description |
| 1410-30 | 10 x 300mL Bottles / Box |
Cystografin
Indicated for retrograde cystourethrography.
| Cat No. | Description |
| 0149-60 | 10 x 100mL Bottles / Box |
| 0149-57 | 10 x 300mL Bottles / Box |